To evaluate the tumorigenic potential and in vivo tumor growth of CD133+ and CD133− DLD-1 cells, we transplanted serial numbers of CD133+ and CD133− cells into severe combined immunodeficiency (SCID) mice. The gene discussed is PROM1; the disease is neoplasm.